Skip to main content
. 2017 Jan 20;12(1):e0170654. doi: 10.1371/journal.pone.0170654

Fig 3. 25OHD3 increases expression of TRPV6 and Calbindin-D9k in duodenum of CYP27B1-/- mice with CKD.

Fig 3

A: TRPV6 B: Calbindin-D9K and C: PMCA1b mRNA expression (qPCR) in CYP27B1+/+ (WT) and CYP27B1-/- (KO) control mice, nephrectomized (nx) and nephrectomized treated with 25OHD3 for 1 month. Data are mean ± SEM * p< 0,001 vs. WT, # p< 0,05 vs. Control, † p< 0,05 vs. Nx, (n = 5 to 7).